Lexicon to Present Study Results Relating to LX9211 and INPE

LX9211 is an investigational, non-opioid treatment for diabetic peripheral neuropathic pain

Related Keywords

Boston , Massachusetts , United States , California , San Diego , Texas , Ann Arbor , Michigan , San Diego Convention Center , American , Carrie Siragusa , Rahul Aggarwal , Bristol Myers Squibb , Alina Cocuzza , Department Of Internal Medicine , Harvard Medical School , University Of Michigan , Lexicon Pharmaceuticals Inc , Exchange Commission , Drug Administration , Division Of Metabolism , Nasdaq , Lexicon Pharmaceuticals , American Diabetes Association , Oral Presentations , Scientific Sessions , Fast Track , Painful Diabetic Peripheral Neuropathy , Multicenter Study , Rodica Pop Busui , Internal Medicine , Heart Failure Related Outcomes , Select Abstract Session , Investor Inquiries , Media Inquiries ,